Lv21
180 积分 2025-07-06 加入
11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050
2小时前
已完结
Efficacy and safety of janagliflozin monotherapy in Chinese patients with type 2 diabetes mellitus inadequately controlled on diet and exercise: A multicentre, randomized, double‐blind, placebo‐controlled, Phase 3 trial
4天前
已完结
Icosapent ethyl, a pure EPA omega-3 fatty acid: Effects on lipoprotein particle concentration and size in patients with very high triglyceride levels (the MARINE study)
28天前
已完结
Effect of Targeting ApoC-III With Plozasiran on Lipoprotein Particle Size and Number in Hypertriglyceridemia
1个月前
已完结
Lepodisiran: Effects on Lipoprotein(a) and Cardiovascular Outcomes in Adults with Elevated Lp(a)
1个月前
已完结
Lipoprotein(a) - treatments in development
1个月前
已完结
APOC3 siRNA and ASO therapy for dyslipidemia
2个月前
已完结
Expanding the triglyceride range in clinical trials: therapeutic opportunities
2个月前
已完结
Reaching for the stars: a wider perspective for designing future cardiovascular outcome trials of triglyceride-lowering therapies
2个月前
已关闭
Targeting Triglycerides: The Rise of Apolipoprotein C3 and Angiopoietin-Like Protein 3 Inhibitors
2个月前
已完结
Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial
1个月前
已采纳
Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN
1个月前
已采纳
Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN
1个月前
已采纳
Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN
1个月前
已采纳
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
5个月前
已采纳
天然低共熔溶剂提取姜黄素类化合物的研究
6个月前
已采纳
皖公网安备34019202002308
